Paola Preti

ORCID: 0000-0003-1624-4029
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood Pressure and Hypertension Studies
  • Pharmacology and Obesity Treatment
  • Hormonal Regulation and Hypertension
  • Heart Rate Variability and Autonomic Control
  • Atrial Fibrillation Management and Outcomes
  • Diabetes Treatment and Management
  • Hormonal and reproductive studies
  • Cardiovascular Syncope and Autonomic Disorders
  • COVID-19 Clinical Research Studies
  • Venous Thromboembolism Diagnosis and Management
  • Adipokines, Inflammation, and Metabolic Diseases
  • Sexual function and dysfunction studies
  • Sodium Intake and Health
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Arrhythmias and Treatments
  • Adrenal and Paraganglionic Tumors
  • Lipoproteins and Cardiovascular Health
  • Hemophilia Treatment and Research
  • COVID-19 and healthcare impacts
  • Renin-Angiotensin System Studies
  • Cardiac, Anesthesia and Surgical Outcomes
  • Regulation of Appetite and Obesity
  • Apelin-related biomedical research
  • Blood Coagulation and Thrombosis Mechanisms
  • Adrenal Hormones and Disorders

University of Pavia
2008-2024

Istituti di Ricovero e Cura a Carattere Scientifico
2005-2022

Policlinico San Matteo Fondazione
1996-2022

Corvid Technologies (United States)
2021

Haemophilia Foundation Australia
2020

10.1007/s10238-020-00679-4 article EN other-oa Clinical and Experimental Medicine 2021-01-08

Hypothalamic-pituitary function was studied in 45 patients with idiopathic GH deficiency (GHD), 33 of whom had pituitary abnormalities on magnetic resonance imaging: hypoplasia, undescended stalk and ectopia the posterior lobe 8 isolated GHD (IGHD) (group I) 12 multiple hormone (MPHD) II); hypoplasia 13 IGHD III); no evidence remaining IV). Sellar volumes were significantly lower groups I, II, III than group IV (P less 0.001). No significant differences observed between I II response to...

10.1210/jcem-73-1-79 article EN The Journal of Clinical Endocrinology & Metabolism 1991-07-01

The aim of this study was to compare the effects angiotensin-converting enzyme (ACE) inhibitor perindopril and angiotensin II antagonist losartan on insulin sensitivity plasma fibrinogen in overweight hypertensive patients. Twenty-eight mild moderate [diastolic blood pressure (DBP) >90 <110 mm Hg] hypertensives aged 43-64 years, after a 4-week placebo period, were randomized perindopril, 4 mg o.d., or losartan, 50 for 6 weeks. Then, new patients crossed alternative regimen further At end...

10.1097/00005344-199810000-00014 article EN Journal of Cardiovascular Pharmacology 1998-10-01

This study compared the effect of antihypertensive treatment with valsartan or ramipril on atrial fibrillation (AF) recurrence, P-wave dispersion, (PWD) and serum procollagen type I carboxy terminal peptide (PIP).A total 369 mild hypertensive (systolic blood pressure (SBP) >140 and/or 90 < diastolic (DBP) 110 mm Hg) outpatients in sinus rhythm but at least two episodes AF previous 6 months were randomized to (n = 122), 124), amlodipine 123) for 1 year. Clinic (BP) a 24-h electrocardiogram...

10.1038/ajh.2008.217 article EN American Journal of Hypertension 2008-06-19
Marco Vincenzo Lenti F. Borrelli De Andreis Ivan Pellegrino Catherine Klersy Stefania Merli and 92 more Emanuela Miceli Nicola Aronico Caterina Mengoli M. Di Stefano Sara Cococcia Giovanni Santacroce Simone Soriano Federica Melazzini Mariangela Delliponti Fausto Baldanti Antonio Triarico Gino Roberto Corazza Massimo Pinzani Antonio Di Sabatino Gaetano Bergamaschi Giampiera Bertolino Silvia Codega Filippo Costanzo Roberto Cresci Giuseppe Derosa Francesco Falaschi Carmine Iadarola Elisabetta Lovati Pietro Carlo Lucotti Alessandra Martignoni Amedeo Mugellini Chiara Muggia Patrizia Noris Elisabetta Pagani Ilaria Palumbo Alessandro Pecci Tiziano Perrone Carla Pieresca Paola Preti Mariaconcetta Russo C. Sgarlata Luisa Siciliani Andrea Staniscia Francesca Torello Vjera Giovanna Achilli Andrea Agostinelli Valentina Antoci Alessia Ballesio F Banfi Chiara Barteselli Irene Benedetti M Brattoli Francesca Calabretta Ginevra Cambiè Roberta Canta Federico Conca Luigi Coppola Elisa Maria Cremonte Gabriele Croce Virginia Del Rio Francesco Di Terlizzi Maria Giovanna Ferrari Sara Ferrari Anna Fiengo Tommaso Forni Giulia Freddi Chiara Frigerio F Fumoso Alessandra Fusco Margherita Gabba Matteo Garolfi Antonella Gentile Giulia Gori G.F. De Grandi Paolo Grimaldi Alice Lampugnani F Lapia Federica Lepore Gianluca Lettieri Jacopo Mambella C. Mercanti Francesco Mordà Alba Nardone Luca Pace Lucia Padovini Alessandro Parodi Lavinia Pitotti Margherita Reduzzi Giovanni Rigano Giorgio Rotola Umberto Sabatini Lucia Salvi Giovanni Santacroce Jessica Savioli Simone Soriano Carmine Spataro Debora Stefani

Little is known regarding coronavirus disease 2019 (COVID-19) clinical spectrum in non-Asian populations. We herein describe the impact of COVID-19 on liver function 100 consecutive patients (median age 70 years, range 25-97; 79 males) who were admitted to our internal medicine unit March 2020. retrospectively assessed tests, taking into account demographic characteristics and outcome. A patient was considered as having injury when alanine aminotransferase (ALT) > 50 mU/ml, gamma-glutamyl...

10.1007/s11739-020-02425-w article EN cc-by Internal and Emergency Medicine 2020-07-10

COVID-19 infection causes respiratory pathology with severe interstitial pneumonia and extra-pulmonary complications; in particular, it may predispose to thromboembolic disease. The current guidelines recommend the use of thromboprophylaxis patients COVID-19, however, optimal heparin dosage treatment is not well-established. We conducted a multicentre, Italian, retrospective, observational study on admitted ordinary wards, describe clinical characteristic at admission, bleeding thrombotic...

10.1007/s11739-021-02891-w article EN cc-by Internal and Emergency Medicine 2022-01-01

Background:This study compared the effects of losartan and perindopril on plasma plasminogen activator inhibitor-1 (PAI-1) fibrinogen in hypertensive type 2 diabetic patients.

10.1016/s0895-7061(01)02340-8 article EN American Journal of Hypertension 2002-04-01

Background:The aim of this study was to evaluate the effect valsartan compared with atenolol on sexual behavior in hypertensive postmenopausal women.

10.1016/j.amjhyper.2003.08.016 article EN American Journal of Hypertension 2003-12-30

The aim of this study was to compare the effect valsartan/amlodipine and atenolol/amlodipine combination in preventing recurrence atrial fibrillation (AF) hypertensive diabetic patients with a history recent paroxysmal fibrillation. Two hundred ninty-six well-controlled type 2 diabetes sinus rhythm but at least ECG-documented episodes AF previous 6 months were randomized 160 mg valsartan plus amlodipine (titrated from 2.5 10 mg) or 100 atenolol (2.5 addition their antiarrhythmic treatment...

10.1097/fjc.0b013e318160b42a article EN Journal of Cardiovascular Pharmacology 2008-03-01

Journal Article Effect of Telmisartan–Amlodipine Combination at Different Doses on Urinary Albumin Excretion in Hypertensive Diabetic Patients With Microalbuminuria: Get access Roberto Fogari, Fogari 1Department Internal Medicine and Therapeutics, Clinica Medica II-IRCCS Policlinico S. Matteo, University Pavia, Italy Address correspondence reprint requests to Dr. II, P. le Golgi, 19, 27100 E-mail: [email protected] Search for other works by this author on: Oxford Academic PubMed Google...

10.1016/j.amjhyper.2006.10.002 article EN American Journal of Hypertension 2007-03-24

This study evaluated the effect of telmisartan, ramipril, and amlodipine on atrial fibrillation (AF) recurrence severity in hypertensive patients with metabolic syndrome. A total 391 outpatients syndrome, sinus rhythm but at least 2 episodes AF previous 6 months were randomized to or for 1 year. At first AF, ventricular rate (VR) plasma cardiac troponin I (TnI) evaluated. P-wave dispersion (PWD) procollagen type carboxy-terminal peptide (PIP) before after 12 treatment. Systolic blood...

10.1177/1074248410395018 article EN Journal of Cardiovascular Pharmacology and Therapeutics 2011-02-18

Objective The aim of this study was to compare the chronic effects four dihydropyridine calcium antagonists with different pharmacologic characteristics, amlodipine, felodipine, lacidipine and manidipine, on blood pressure (BP), heart rate (HR) plasma norepinephrine (NE) levels in patients mild moderate essential hypertension. Method After a 4-week placebo period, 60 both sexes were randomly administered amlodipine 5–10 mg once daily (o.d.) (n = 15); felodipine o.d. 4–6 manidipine 10–20 15),...

10.1097/00004872-200018120-00023 article EN Journal of Hypertension 2000-12-01
Coming Soon ...